Mohammadhossein Hassanshahi

Research Interests

Cardiac, Respiratory and Vascular Health Cardiovascular System & Hematology

Dr Mohammadhossein Hassanshahi

Research Fellow

Centre for Cancer Biology

College of Health

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.

I am a scientist specializing in tissue regeneration and cancer biology, with over 14 years of laboratory experience. My research spans wound healing, skin regeneration, and cancer vascularization.I am highly skilled in bio-scaffold engineering, with expertise in tissue decellularization, vascularization, and hydrogel formulation, as well as advanced 3D culture systems and patient-derived models for translational research. My technical strengths include molecular biology, cell and tissue culture, histological analysis, and small animal surgery, enabling comprehensive investigation from bench to clinical application.Driven by innovation and scientific rigor, I bring a strong combination of technical expertise, project management, and collaborative research experience. I am passionate about translating scientific discoveries into clinical and commercial applications and am eager to contribute to impactful R&D initiatives in regenerative medicine and oncology.

Date Position Institution name
2020 - ongoing National Heart Foundation Postdoctoral Research Fellow University of Adelaide
2018 - 2018 Postdoctoral Research Associate University of South Australia
2017 - 2019 Postdoctoral Research Associate University of South Australia
2017 - 2018 Research Officer University of Adelaide

Date Institution name Country Title
2013 - 2017 University of South Australia Australia PhD
2011 - 2012 University of East Anglia United Kingdom M.Sc

Year Citation
2024 Williamson, A. E., Liyanage, S., Hassanshahi, M., Dona, M. S. I., Toledo-Flores, D., Tran, D. X. A., . . . Psaltis, P. J. (2024). Discovery of an embryonically derived bipotent population of endothelial-macrophage progenitor cells in postnatal aorta. Nature Communications, 15(1), 7097-1-7097-21.
DOI Scopus8 WoS8 Europe PMC6
2022 Peymanfar, Y., Su, Y. W., Hassanshahi, M., & Xian, C. J. (2022). Methotrexate treatment suppresses osteoblastic differentiation by inducing Notch2 signaling and blockade of Notch2 rescues osteogenesis by preserving Wnt/β-catenin signaling. Journal of Orthopaedic Research, 40(10), 2258-2270.
DOI Scopus5 WoS6 Europe PMC4
2022 Peymanfar, Y., Su, Y. W., Hassanshahi, M., & Xian, C. J. (2022). Therapeutic Targeting Notch2 Protects Bone Micro-Vasculatures from Methotrexate Chemotherapy-Induced Adverse Effects in Rats. Cells, 11(15), 2382-1-2382-21.
DOI Scopus1 Europe PMC1
2022 Hassanshahi, A., Moradzad, M., Ghalamkari, S., Fadaei, M., Cowin, A. J., & Hassanshahi, M. (2022). Macrophage-Mediated Inflammation in Skin Wound Healing. Cells, 11(19), 2953-1-2953-14.
DOI Scopus248 WoS235 Europe PMC172
2021 Fan, J., Su, Y. -W., Hassanshahi, M., Fan, C. -M., Peymanfar, Y., Piergentili, A., . . . Xian, C. J. (2021). β-Catenin signaling is important for osteogenesis and hematopoiesis recovery following methotrexate chemotherapy in rats. Journal of Cellular Physiology, 236(5), 3740-3751.
DOI Scopus6 WoS5 Europe PMC4
2020 Tang, Q., Su, Y., Fan, C., Chung, R., Hassanshahi, M., Peymanfar, Y., & Xian, C. (2020). Erratum to: Release of CXCL12 From Apoptotic Skeletal Cells Contributes to Bone Growth Defects Following Dexamethasone Therapy in Rats: CHEMOKINE CXCL12 IN DEX THERAPY-INDUCED BONE GROWTH DEFECTS (Journal of Bone and Mineral Research, (2019), 34, 2, (310-326), 10.1002/jbmr.3597). Journal of Bone and Mineral Research, 35(8), 1612-1613.
DOI Scopus2 WoS1 Europe PMC1
2019 Hassanshahi, M., Su, Y. W., Fan, C. M., Khabbazi, S., Hassanshahi, A., & Xian, C. J. (2019). Methotrexate chemotherapy–induced damages in bone marrow sinusoids: an in vivo and in vitro study. Journal of Cellular Biochemistry, 120(3), 3220-3231.
DOI Scopus14 WoS15
2019 Tang, Q., Su, Y. W., Fan, C. M., Chung, R., Hassanshahi, M., Peymanfar, Y., & Xian, C. J. (2019). Release of CXCL12 from apoptotic skeletal cells contributes to bone growth defects following dexamethasone therapy in rats. Journal of Bone and Mineral Research, 34(2), 310-326.
DOI Scopus6 WoS6 Europe PMC5
2019 Hassanshahi, A., Hassanshahi, M., Khabbazi, S., Hosseini-Khah, Z., Peymanfar, Y., Ghalamkari, S., . . . Xian, C. J. (2019). Adipose-derived stem cells for wound healing. Journal of Cellular Physiology, 234(6), 7903-7914.
DOI Scopus177 WoS157 Europe PMC129
2019 Hassanshahi, M., Su, Y. W., Khabbazi, S., Fan, C. M., Chen, K. M., Wang, J. F., . . . Xian, C. J. (2019). Flavonoid genistein protects bone marrow sinusoidal blood vessels from damage by methotrexate therapy in rats. Journal of Cellular Physiology, 234(7), 11276-11286.
DOI Scopus12 WoS12 Europe PMC7
2019 Hassanshahi, M., Khabbazi, S., Peymanfar, Y., Hassanshahi, A., Hosseini-Khah, Z., Su, Y. W., & Xian, C. J. (2019). Critical limb ischemia: current and novel therapeutic strategies. Journal of Cellular Physiology, 234(9), 14445-14459.
DOI Scopus24 WoS21 Europe PMC17
2019 Khabbazi, S., Hassanshahi, M., Hassanshahi, A., Peymanfar, Y., Su, Y. W., & Xian, C. J. (2019). Opioids and matrix metalloproteinases: the influence of morphine on MMP-9 production and cancer progression. Naunyn-Schmiedeberg's Archives of Pharmacology, 392(2), 123-133.
DOI Scopus18 WoS20 Europe PMC16
2019 Hassanshahi, M., Su, Y. W., Khabbazi, S., Fan, C. M., Tang, Q., Wen, X., . . . Xian, C. J. (2019). Icariin attenuates methotrexate chemotherapy-induced bone marrow microvascular damage and bone loss in rats. Journal of Cellular Physiology, 234(9), 16549-16561.
DOI Scopus7 WoS8 Europe PMC3
2019 Hassanshahi, M., Hassanshahi, A., Khabbazi, S., Su, Y. W., & Xian, C. J. (2019). Bone marrow sinusoidal endothelium as a facilitator/regulator of cell egress from the bone marrow. Critical Reviews in Oncology/Hematology, 137, 43-56.
DOI Scopus21 WoS18 Europe PMC16
2019 Hassanshahi, M., Anderson, P. H., Sylvester, C. L., & Stringer, A. M. (2019). Highlight article: Current evidence for vitamin D in intestinal function and disease. Experimental Biology and Medicine, 244(12), 1040-1052.
DOI Scopus13 WoS12 Europe PMC6
2018 Su, Y. W., Chim, S. M., Zhou, L., Hassanshahi, M., Chung, R., Fan, C., . . . Xian, C. J. (2018). Osteoblast derived-neurotrophin‑3 induces cartilage removal proteases and osteoclast-mediated function at injured growth plate in rats. Bone, 116, 232-247.
DOI Scopus18 WoS16 Europe PMC13
2017 Su, Y., Chen, K., Hassanshahi, M., Tang, Q., Howe, P., & Xian, C. (2017). Childhood cancer chemotherapy-induced bone damage: pathobiology and protective effects of resveratrol and other nutraceuticals. Annals of the New York Academy of Sciences, 1403(1), 109-117.
DOI Scopus19 WoS16 Europe PMC13
2017 Hassanshahi, M., Hassanshahi, A., Khabbazi, S., Su, Y., & Xian, C. (2017). Bone marrow sinusoidal endothelium: damage and potential regeneration following cancer radiotherapy or chemotherapy. Angiogenesis, 20(4), 427-442.
DOI Scopus43 WoS43 Europe PMC36
2016 Su, Y. W., Chung, R., Ruan, C. S., Chim, S. M., Kuek, V., Dwivedi, P. P., . . . Xian, C. J. (2016). Neurotrophin-3 induces BMP-2 and VEGF activities and promotes the bony repair of injured growth plate cartilage and bone in rats. Journal of Bone and Mineral Research, 31(6), 1258-1274.
DOI Scopus74 WoS64 Europe PMC58
2012 Hassanshahi, M., & Poschl, E. (2012). Matricellular proteins: recombinant expression of Smoc2 and Periostin in vascular cells. Life science journal, 9(4), 4300-4314.
Scopus1
2012 Hassanshahi, M., Khabbazi, S., Hassanshahi, A. R., & Mohammadi, O. (2012). Angiogenesis and current approaches to deal with its misregulation in related diseases. Life science journal, 9(4), 4892-4902.

Connect With Me

External Profiles

Other Links